PUMA BIOTECHNOLOGY, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2019
Total Assets: $234.9M
Liabilities Breakdown FY2019
Total Liabilities: $217.4M
Asset Breakdown
Total Assets: $234.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $60.0M | 25.6% |
| Accounts Receivable | $28.9M | 12.3% |
| Inventory | $3.2M | 1.3% |
| Property, Plant & Equipment | $3.3M | 1.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $40.5M | 17.2% |
| Other Assets | $99.0M | 42.2% |
Liabilities Breakdown
Total Liabilities: $217.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $19.2M | 8.8% |
| Long-Term Debt | $95.0M | 43.7% |
| Other Liabilities | $103.3M | 47.5% |